blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3888692

EP3888692 - STRIATIN INTERACTING PROTEIN INHIBITOR AND USE THEREOF IN PREPARATION OF ANTI-TUMOR DRUG [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  03.09.2021
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  24.04.2020
Most recent event   Tooltip17.05.2024New entry: Decision on request for further processing 
Applicant(s)For all designated states
Hangzhou Gongchu Biotechnology Co., Ltd
Room 1-310, Heda Medicine Valley Center
No. 291, Fucheng Road, Xiasha Street
Economic and Technological
Development Zone, Jianggan District
Hangzhou Zhejiang 310018 / CN
[2021/40]
Inventor(s)01 / LI, Gongchu
Room 309, College of Life Sciences and Medicine
Zhejiang Sci-Tech University
Hangzhou City, Zhejiang 310018 / CN
 [2021/40]
Representative(s)Vitina, Maruta, et al
Agency TRIA ROBIT
P.O. Box 22
1010 Riga / LV
[N/P]
Former [2021/40]Lang, Christian
LangPatent Anwaltskanzlei IP Law Firm
Ingolstädter Straße 5
80807 München / DE
Application number, filing date19874712.312.10.2019
[2021/40]
WO2019CN110713
Priority number, dateCN20181121576318.10.2018         Original published format: CN201811215763
[2021/40]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020078274
Date:23.04.2020
Language:ZH
[2020/17]
Type: A1 Application with search report 
No.:EP3888692
Date:06.10.2021
Language:EN
[2021/40]
Search report(s)International search report - published on:CN23.04.2020
(Supplementary) European search report - dispatched on:EP13.06.2023
ClassificationIPC:A61K48/00, A61K35/768, A61P35/00, A61P35/04, C12N15/63, C12N15/113
[2021/40]
CPC:
C12N15/113 (EP,CN); A61K48/005 (CN); C12N15/1137 (US);
A61K35/768 (EP,CN,US); A61P35/00 (EP,CN,US); A61P35/04 (EP,CN);
C12N15/63 (EP,CN); C12N15/86 (EP); C12N2310/14 (CN,US);
C12N2310/531 (US); C12N2710/24132 (US); C12N2710/24143 (EP,US);
Y02A50/30 (EP) (-)
C-Set:
C12N2310/14, C12N2310/531 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/40]
TitleGerman:MIT STRIATIN INTERAGIERENDER PROTEININHIBITOR UND VERWENDUNG DAVON ZUR HERSTELLUNG EINES ANTITUMORARZNEIMITTELS[2021/40]
English:STRIATIN INTERACTING PROTEIN INHIBITOR AND USE THEREOF IN PREPARATION OF ANTI-TUMOR DRUG[2021/40]
French:INHIBITEUR DE PROTÉINE INTERAGISSANT AVEC LA STRIATINE ET SON UTILISATION DANS LA PRÉPARATION D'UN MÉDICAMENT ANTI-TUMORAL[2021/40]
Entry into regional phase13.08.2021Translation filed 
13.07.2021National basic fee paid 
13.07.2021Search fee paid 
13.07.2021Designation fee(s) paid 
13.07.2021Examination fee paid 
Examination procedure13.05.2020Request for preliminary examination filed
International Preliminary Examining Authority: CN
deletedDeletion: Application deemed to be withdrawn, date of legal effect  [2021/40]
13.07.2021Examination requested  [2021/40]
26.03.2024Amendment by applicant (claims and/or description)
Request for further processing for:The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
26.03.2024Request for further processing filed
26.03.2024Full payment received (date of receipt of payment)
Request granted
04.04.2024Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
26.03.2024Request for further processing filed
26.03.2024Full payment received (date of receipt of payment)
Request granted
04.04.2024Decision despatched
The application is deemed to be withdrawn due to failure to file the translation
13.08.2021Request for further processing filed
13.08.2021Full payment received (date of receipt of payment)
Request granted
24.08.2021Decision despatched
The application is deemed to be withdrawn due to non-payment of the search fee
13.07.2021Request for further processing filed
13.07.2021Full payment received (date of receipt of payment)
Request granted
24.08.2021Decision despatched
The application is deemed to be withdrawn due to non-payment of the filing fee
13.07.2021Request for further processing filed
13.07.2021Full payment received (date of receipt of payment)
Request granted
24.08.2021Decision despatched
The application is deemed to be withdrawn due to non-payment of the examination fee
13.07.2021Request for further processing filed
13.07.2021Full payment received (date of receipt of payment)
Request granted
24.08.2021Decision despatched
13.07.2021Request for further processing filed
13.07.2021Full payment received (date of receipt of payment)
Request granted
24.08.2021Decision despatched
The application is deemed to be withdrawn due to non-payment of designation fees
TR, SM, SK, SI, SE, RS, RO, PT, PL, NO, NL, MT, MK, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT, AL
13.07.2021Request for further processing filed
13.07.2021Full payment received (date of receipt of payment)
Request granted
24.08.2021Decision despatched
Fees paidRenewal fee
29.10.2021Renewal fee patent year 03
28.04.2023Renewal fee patent year 04
31.10.2023Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.10.202204   M06   Fee paid on   28.04.2023
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]  - SIAU WEI BAI ET AL, "Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration", BMC BIOLOGY, BIOMED CENTRAL, LONDON, GB, GB, (20110811), vol. 9, no. 1, doi:10.1186/1741-7007-9-54, ISSN 1741-7007, page 54, XP021109296 [X] 1-4,8 * page 15, column left, paragraph 4 * * figure 5 * [I] 5-7

DOI:   http://dx.doi.org/10.1186/1741-7007-9-54
    [ ] - Siau Wei Bai ET AL, "Supplementary Table S3 to Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration", BMC BIOLOGY, BIOMED CENTRAL, LONDON, GB, GB, vol. 9, 54 (2011), (20110811), URL: https://bmcbiol.biomedcentral.com/articles/10.1186/1741-7007-9-54#MOESM14, (20230531), XP093050602 [ ] * the whole document *
 [XI]  - Suryavanshi Narendra, "Functional characterisation of FAM40A and FAM40B as novel regulators of the cytoskeleton", Student thesis: Doctoral Thesis > Doctor of Philosophy, King's College London, (20130501), URL: https://kclpure.kcl.ac.uk/ws/portalfiles/portal/106979093/2013_Suryavanshi_Narendra_0839915_ethesis.pdf, (20230530), XP093050490 [X] 1-4,8 * table 2.4 * * figures 4.1, 4.2 * * page 76, paragraph 4 * * page 149, paragraph 2 * [I] 5-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.